A detailed history of Neos Investment Management LLC transactions in Nuvalent, Inc. stock. As of the latest transaction made, Neos Investment Management LLC holds 10,477 shares of NUVL stock, worth $882,372. This represents 0.03% of its overall portfolio holdings.

Number of Shares
10,477
Previous 9,817 6.72%
Holding current value
$882,372
Previous $745 Million 43.92%
% of portfolio
0.03%
Previous 0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$67.44 - $112.17 $44,510 - $74,032
660 Added 6.72%
10,477 $1.07 Billion
Q2 2024

Aug 14, 2024

BUY
$62.76 - $81.61 $443,022 - $576,084
7,059 Added 255.95%
9,817 $745 Million
Q1 2024

May 13, 2024

BUY
$72.35 - $88.99 $199,541 - $245,434
2,758 New
2,758 $207 Million

Others Institutions Holding NUVL

About Nuvalent, Inc.


  • Ticker NUVL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,977,800
  • Market Cap $3.62B
  • Description
  • Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...
More about NUVL
Track This Portfolio

Track Neos Investment Management LLC Portfolio

Follow Neos Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neos Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neos Investment Management LLC with notifications on news.